Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 852-871 , November 2008

Biopsy of the pigmented lesion—When and how

  • Kien T. Tran, MD, PhD

      Affiliations

    • Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • Natalie A. Wright, BS

      Affiliations

    • University of Texas, Houston, Texas
    • ,
  • Clay J. Cockerell, MD

      Affiliations

    • Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
    • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
    • Corresponding Author InformationReprint requests: Clay J. Cockerell, MD, Professor, Departments of Dermatology and Pathology, University of Texas Southwestern Medical Center, 2330 Butler St, Suite 115, Dallas, TX 75235.

References 

  1. Chen SC, Pennie ML, Kolm P, Warshaw EM, Weisberg EL, Brown KM, et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med. 2006;21:678–682
  2. Reeck MC, Chuang TY, Eads TJ, Faust HB, Farmer ER, Hood AF. The diagnostic yield in submitting nevi for histologic examination. J Am Acad Dermatol. 1999;40:567–571
  3. McKenna DB, Marioni JC, Lee RJ, Prescott RJ, Doherty VR. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol. 2004;151(3):636–644
  4. Morton CA, Mackie RM. Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol. 1998;138:283–287
  5. Khorshid SM, Pinney E, Bishop JA. Melanoma excision by general practitioners in north-east Thames region. England. Br J Dermatol. 1998;138:412–417
  6. Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ. Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol. 1990;126:763–766
  7. Koh HK, Lew RA, Prout MN. Screening for melanoma/skin cancer: theoretic and practical considerations. J Am Acad Dermatol. 1989;20:159–172
  8. Chen SC, Bravata DM, Weil E, Olkin I. A comparison of dermatologists' and primary care physicians' accuracy in diagnosing melanoma: a systematic review. Arch Dermatol. 2001;137:1627–1634
  9. Osborne JE, Chave TA, Hutchinson PE. Comparison of diagnostic accuracy for cutaneous malignant melanoma between general dermatology, plastic surgery and pigmented lesion clinics. Br J Dermatol. 2003;148:252–258
  10. Gachter T, Muhleisen B, Scharer L, Dummer R, Burg G, Hofbauer GF. Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg. 2007;11:9–18
  11. Weatherhead SC, Lawrence CM. Melanoma screening clinics: are we detecting more melanomas or reassuring the worried well?. Br J Dermatol. 2006;154:539–541
  12. Lange JR, Balch CM. Screening for cutaneous melanoma. Surg Oncol Clin North Am. 2005;14:799–811
  13. Pacifico MD, Pearl RA, Grover R. The UK Government two-week rule and its impact on melanoma prognosis: an evidence-based study. Ann R Coll Surg Engl. 2007;89:609–615
  14. Fader DJ, Wise CG, Normolle DP, Johnson TM. The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. J Am Acad Dermatol. 1998;38:742–751
  15. Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol. 2007;143:21–28
  16. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131–149quiz 182-4
  17. Moynihan GD. The 3 Cs of melanoma: time for a change?. J Am Acad Dermatol. 1994;30:510–511
  18. Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292:2771–2776
  19. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35:130–151
  20. Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology. 1998;197:11–17
  21. Hazen BP, Bhatia AC, Zaim T, Brodell RT. The clinical diagnosis of early malignant melanoma: expansion of the ABCD criteria to improve diagnostic sensitivity. Dermatol Online J. 1999;5:3
  22. Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol. 2005;141:998–1006
  23. Grob JJ, Bonerandi JJ. The ‘ugly duckling’ sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134:103–104
  24. Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000;42:269–274
  25. Keefe M, Dick DC, Wakeel RA. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol. 1990;15:167–171
  26. Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol. 1994;130:48–50
  27. McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. J Dermatol Surg Oncol. 1992;18:22–26
  28. Gachon J, Beaulieu P, Sei JF, Gouvernet J, Claudel JP, Lemaitre M, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol. 2005;141:434–438
  29. Scope A, Dusza SW, Halpern AC, Rabinovitz H, Braun RP, Zalaudek I, et al. The “ugly duckling” sign: agreement between observers. Arch Dermatol. 2008;144:58–64
  30. Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermato. 2003;48:679–693
  31. Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol. 2002;46:674–682
  32. Charles CA, Yee VS, Dusza SW, Marghoob AA, Oliveria SA, Kopf A, et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. Arch Dermatol. 2005;141:723–729
  33. Binder M, Schwarz M, Winkler A, Steiner A, Kaider A, Wolff K, et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol. 1995;131:286–291
  34. Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol. 2001;137:1343–1350
  35. Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol. 2000;143:1016–1020
  36. Binder M, Puespoeck-Schwarz M, Steiner A, Kittler H, Muellner M, Wolff K, et al. Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists. J Am Acad Dermatol. 1997;36:197–202
  37. Soyer HP, Argenziano G, Zalaudek I, Corona R, Sera F, Talamini R, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology. 2004;208:27–31
  38. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3:159–165
  39. Argenziano G, Puig S, Zalaudek I, Sera F, Corona R, Alsina M, et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol. 2006;24:1877–1882
  40. Carli P, de Giorgi V, Chiarugi A, Nardini P, Weinstock MA, Crocetti E, et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol. 2004;50:683–689
  41. Carli P, De Giorgi V, Crocetti E, Mannone F, Massi D, Chiarugi A, et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the ‘dermoscopy era’: a retrospective study 1997-2001. Br J Dermatol. 2004;150:687–692
  42. Malvehy J, Puig S, Argenziano G, Marghoob AA, Soyer HP. Dermoscopy report: proposal for standardization. Results of a consensus meeting of the International Dermoscopy Society. J Am Acad Dermatol. 2007;57:84–95
  43. Carli P, De Giorgi V, Giannotti B. Dermoscopy as a second step in the diagnosis of doubtful pigmented skin lesions: how great is the risk of missing a melanoma?. J Eur Acad Dermatol Venereol. 2001;15:24–26
  44. Carli P, De Giorgi V, Argenziano G, Palli D, Giannotti B. Pre-operative diagnosis of pigmented skin lesions: in vivo dermoscopy performs better than dermoscopy on photographic images. J Eur Acad Dermatol Venereol. 2002;16:339–346
  45. Seidenari S, Longo C, Giusti F, Pellacani G. Clinical selection of melanocytic lesions for dermoscopy decreases the identification of suspicious lesions in comparison with dermoscopy without clinical preselection. Br J Dermatol. 2006;154:873–879
  46. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol. 1987;17:571–583
  47. Nachbar F, Stolz W, Merkle T, Cognetta AB, Vogt T, Landthaler M, et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30:551–559
  48. Menzies SW, Ingvar C, Crotty KA, McCarthy WH. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol. 1996;132:1178–1182
  49. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998;134:1563–1570
  50. Binder M, Kittler H, Steiner A, Dawid M, Pehamberger H, Wolff K. Reevaluation of the ABCD rule for epiluminescence microscopy. J Am Acad Dermatol. 1999;40:171–176
  51. Blum A, Rassner G, Garbe C. Modified ABC-point list of dermoscopy: a simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions. J Am Acad Dermatol. 2003;48:672–678
  52. Dolianitis C, Kelly J, Wolfe R, Simpson P. Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions. Arch Dermatol. 2005;141:1008–1014
  53. Annessi G, Bono R, Sampogna F, Faraggiana T, Abeni D. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas. J Am Acad Dermatol. 2007;56:759–767
  54. Carli P, Quercioli E, Sestini S, Stante M, Ricci L, Brunasso G, et al. Pattern analysis, not simplified algorithms, is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology. Br J Dermatol. 2003;148:981–984
  55. Pagnanelli G, Soyer HP, Argenziano G, Talamini R, Barbati R, Bianchi L, et al. Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts. Br J Dermatol. 2003;148:698–702
  56. Skvara H, Teban L, Fiebiger M, Binder M, Kittler H. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol. 2005;141:155–160
  57. Mallon E, Dawber RP. Longitudinal melanonychia induced by minocycline. Br J Dermatol. 1994;130:794–795
  58. Tosti A, Gaddoni G, Fanti PA, D'Antuono A, Albertini F. Longitudinal melanonychia induced by 3′-azidodeoxythymidine. Report of 9 cases. Dermatologica. 1990;180:217–220
  59. Mooney E, Bennett RG. Periungual hyperpigmentation mimicking Hutchinson's sign associated with minocycline administration. J Dermatol Surg Oncol. 1988;14:1011–1013
  60. Baran R. Longitudinal melanotic streaks as a clue to Laugier-Hunziker syndrome. Arch Dermatol. 1979;115:1448–1449
  61. Bissell GW, Surakomol K, Greenslit F. Longitudinal banded pigmentation of nails in primary adrenal insufficiency. JAMA. 1971;215:1666–1667
  62. Allenby CF, Snell PH. Longitudinal pigmentation of the nails in Addison's disease. Br Med J. 1966;1:1582–1583
  63. Tosti A, Argenziano G. Dermoscopy allows better management of nail pigmentation. Arch Dermatol. 2002;138:1369–1370
  64. Ronger S, Touzet S, Ligeron C, Balme B, Viallard AM, Barrut D, et al. Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138:1327–1333
  65. Thomas L, Dalle S. Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther. 2007;20:3–10
  66. Braun RP, Baran R, Saurat JH, Thomas L. Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrix. J Am Acad Dermatol. 2006;55:512–513
  67. Jellinek N. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol. 2007;56:803–810
  68. Perrin C, Michiels JF, Pisani A, Ortonne JP. Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. Am J Dermatopathol. 1997;19:462–467
  69. Husain S, Scher RK, Silvers DN, Ackerman AB. Melanotic macule of nail unit and its clinicopathologic spectrum. J Am Acad Dermatol. 2006;54:664–667
  70. Braun RP, Baran R, Le Gal FA, Dalle S, Ronger S, Pandolfi R, et al. Diagnosis and management of nail pigmentations. J Am Acad Dermatol. 2007;56:835–847
  71. Krunic AL, Wang LC, Soltani K, Weitzul S, Taylor RS. Digital anesthesia with epinephrine: an old myth revisited. J Am Acad Dermatol. 2004;51:755–759
  72. Haneke E, Baran R. Longitudinal melanonychia. Dermatol Surg. 2001;27:580–584
  73. Bolognia J, Jorizzo J, Rapini R. Dermatology. 2nd ed.. St Louis: Mosby; 2007;
  74. Wolff K, Fitzpatrick TB, Goldsmith LA, Katz SI, Gilchrest BA, Paller A, et al. Fitzpatrick's Dermatology in general medicine. 7th ed.. New York: McGraw-Hill; 2008;
  75. Bolognia JL. I. Biopsy techniques for pigmented lesions. Dermatol Surg. 2000;26:89–90
  76. Cockerell CJ. Biopsy technique for pigmented lesions. Semin Cutan Med Surg. 1997;16:108–112
  77. Balch CM, Houghton AN, Sober AJ, Soong S. Cutaneous melanoma. 4th ed. St Louis: Quality Medical Publishers; 2003;
  78. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648
  79. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001;45:579–586
  80. Stell VH, Norton HJ, Smith KS, Salo JC, White RL. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007;14:893–898
  81. Swanson NA, Lee KK, Gorman A, Lee HN. Biopsy techniques. Diagnosis of melanoma. Dermatol Clin. 2002;20:677–680
  82. Ho J, Brodell RT, Helms SE. Saucerization biopsy of pigmented lesions. Clin Dermatol. 2005;23:631–635
  83. Molenkamp BG, Sluijter BJ, Oosterhof B, Meijer S, van Leeuwen PA. Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann Surg Oncol. 2007;14:1424–1430
  84. Robinson JK. Surgery of the skin: procedural dermatology. Philadelphia: Elsevier Mosby; 2005;
  85. Mehregan DR, Dooley VN. How to get the most out of your skin biopsies. Int J Dermatol. 2007;46:727–733
  86. Somach SC, Taira JW, Pitha JV, Everett MA. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol. 1996;132:1297–1302
  87. Karimipour DJ, Schwartz JL, Wang TS, Bichakjian CK, Orringer JS, King AL, et al. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol. May 2005;52:798–802
  88. Houghton AN, Coit D, Bichakjian CK, Daud A, Dilawari RA, Dimaio D, et al. NCCN Clinical Practice Guidelines in Oncology: Melanoma. In: Network NCC, ed. V.2.2007 ed; 2007.
  89. Balch CM, Sober AJ, Soong SJ, Gershenwald JE. The new melanoma staging system. Semin Cutan Med Surg. 2003;22:42–54
  90. Funk W, Schmoeckel C, Holzel D, Braun-Falco O. Prognostic classification of malignant melanoma by clinical criteria. Br J Dermatol. 1984;111:129–138
  91. O'Donnell BF, Marsden JR, O'Donnell CA, Sanders DS, Billingham C. Does palpability of primary cutaneous melanoma predict dermal invasion?. J Am Acad Dermatol. 1996;34:632–637
  92. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Delfino M. Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness. J Am Acad Dermatol. 1999;40:61–68
  93. Pagnanelli G, Bono R, Pizzichetta MA, Talamini R, Ascierto PA, Testori A, et al. Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity. Anticancer Res. 2007;27:2939–2944
  94. Ng PC, Barzilai DA, Ismail SA, Averitte RL, Gilliam AC. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?. J Am Acad Dermatol. 2003;48:420–424
  95. Pritchard GA, Hughes LE. Clinical assessment of melanoma thickness. Eur J Surg Oncol. 1989;15:232–235
  96. Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88:1484–1491
  97. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21:43–52
  98. Andersen WK, Silvers DN. ‘Melanoma? It can't be melanoma!’ A subset of melanomas that defies clinical recognition. JAMA. 1991;266:3463–3465
  99. Stevens G, Cockerell CJ. Avoiding sampling error in the biopsy of pigmented lesions. Arch Dermatol. 1996;132:1380–1382
  100. Koller J, Rettenbacher L. The influence of diagnostic biopsies on the sentinel lymph node detection in cutaneous melanoma. Arch Dermatol. 2000;136:1176
  101. Epstein E, Bragg K, Linden G. Biopsy and prognosis of malignant melanoma. JAMA. 1969;208:1369–1371
  102. van der Esch EP, Rampen FH. Punch biopsy of melanoma. J Am Acad Dermatol. 1985;13:899–902
  103. Bong JL, Herd RM, Hunter JA. Incisional biopsy and melanoma prognosis. J Am Acad Dermatol. 2002;46:690–694
  104. Martin RC, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, et al. Is incisional biopsy of melanoma harmful?. Am J Surg. 2005;190:913–917
  105. Griffiths RW, Briggs JC. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl. 1985;67:75–78
  106. Wagner DE, Cullen RA. Primary melanoma: pitfalls in diagnostic biopsy techniques and interpretations. Am J Surg. 1984;148:99–102
  107. Lederman JS, Sober AJ. Does biopsy type influence survival in clinical stage I cutaneous melanoma?. J Am Acad Dermatol. 1985;13:983–987
  108. Griffiths RW, Briggs JC. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl. 1986;68:58
  109. Lees VC, Briggs JC. Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1086 patients. Br J Surg. 1991;78:1108–1110
  110. Rampen FH, van Houten WA, Jop WC. Incisional procedures and prognosis in malignant melanoma. Clin Exp Dermatol. 1980;5:313–320
  111. Austin JR, Byers RM, Brown WD, Wolf P. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck. 1996;18:107–117
  112. Fitzpatrick PJ, Brown TC, Reid J. Malignant melanoma of the head and neck: a clinicopathological study. Can J Surg. 1972;15:90–101
  113. NIH Consensus Conference . Diagnosis and treatment of early melanoma. JAMA. 1992;268:1314–1319
  114. Pariser RJ, Divers A, Nassar A. The relationship between biopsy technique and uncertainty in the histopathologic diagnosis of melanoma. Dermatol Online J. 1999;5:4
  115. Armour K, Mann S, Lee S. Dysplastic naevi: to shave, or not to shave? A retrospective study of the use of the shave biopsy technique in the initial management of dysplastic naevi. Australas J Dermatol. 2005;46:70–75
  116. Witheiler DD, Cockerell CJ. Sensitivity of diagnosis of malignant melanoma: a clinicopathologic study with a critical assessment of biopsy techniques. Exp Dermatol. 1992;1:170–175
  117. Wang SQ, Kopf AW, Koenig K, Polsky D, Nudel K, Bart RS. Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy. J Am Acad Dermatol. 2004;50:15–20
  118. Risser J, Pressley Z, Veledar E, Washington C, Chen SC. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. J Am Acad Dermatol. 2007;57:428–434
  119. Shriner DL, Wagner RF, Glowczwski JR. Photography for the early diagnosis of malignant melanoma in patients with atypical moles. Cutis. 1992;50:358–362
  120. Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol. 1988;124:1239–1243
  121. Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617–628viii
  122. Nehal KS, Oliveria SA, Marghoob AA, Christos PJ, Dusza SW, Tromberg JS, et al. Use of and beliefs about dermoscopy in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States. Melanoma Res. 2002;12:601–605
  123. Halpern AC. Total body skin imaging as an aid to melanoma detection. Semin Cutan Med Surg. 2003;22:2–8
  124. Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Aust. 1997;167:191–194
  125. Stolz W, Schiffner R, Pillet L, Vogt T, Harms H, Schindewolf T, et al. Improvement of monitoring of melanocytic skin lesions with the use of a computerized acquisition and surveillance unit with a skin surface microscopic television camera. J Am Acad Dermatol. 1996;35:202–207
  126. Provost N, Kopf AW, Rabinovitz HS, Stolz W, DeDavid M, Wasti Q, et al. Comparison of conventional photographs and telephonically transmitted compressed digitized images of melanomas and dysplastic nevi. Dermatology. 1998;196:299–304
  127. Massone C, Soyer HP, Hofmann-Wellenhof R, Di Stefani A, Lozzi GP, Gabler G, et al. Two years' experience with Web-based teleconsulting in dermatology. J Telemed Telecare. 2006;12:83–87
  128. Moreno-Ramirez D, Ferrandiz L, Nieto-Garcia A, Carrasco R, Moreno-Alvarez P, Galdeano R, et al. Store-and-forward teledermatology in skin cancer triage: experience and evaluation of 2009 teleconsultations. Arch Dermatol. 2007;143:479–484
  129. Rivers JK, Kopf AW, Vinokur AF, Rigel DS, Friedman RJ, Heilman ER, et al. Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer. 1990;65:1232–1236
  130. Del Mar CB, Green AC. Aid to diagnosis of melanoma in primary medical care. BMJ. 1995;310:492–495
  131. Feit NE, Dusza SW, Marghoob AA. Melanomas detected with the aid of total cutaneous photography. Br J Dermatol. 2004;150:706–714
  132. Kittler H, Guitera P, Riedl E, Avramidis M, Teban L, Fiebiger M, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol. 2006;142:1113–1119
  133. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol. 2001;137:1583–1589
  134. Robinson JK, Nickoloff BJ. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol. 2004;140:49–56
  135. Haenssle HA, Krueger U, Vente C, Thoms KM, Bertsch HP, Zutt M, et al. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol. 2006;126:980–985
  136. Bauer J, Blum A, Strohhacker U, Garbe C. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol. 2005;152:87–92
  137. Marks R, Jolley D, McCormack C, Dorevitch AP. Who removes pigmented skin lesions?. J Am Acad Dermatol. 1997;36:721–726
  138. Nehal KS, Oliveria SA, Marghoob AA, Christos PJ, Dusza S, Tromberg JS, et al. Use of and beliefs about baseline photography in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States. Melanoma Res. 2002;12:161–167
  139. Hudson-Peacock MJ, Bishop J, Lawrence CM. Shave excision of benign papular naevocytic naevi. Br J Plast Surg. 1995;48:318–322
  140. Porter JM, Treasure J. Excision of benign pigmented skin tumours by deep shaving. Br J Plast Surg. 1993;46:255–257
  141. Harvey DT, Fenske NA. The razor blade biopsy technique. Introduction of the adaptor-designed shave biopsy instrument. Dermatol Surg. 1995;21:345–347
  142. Grabski WJ, Salasche SJ, Mulvaney MJ. Razor-blade surgery. J Dermatol Surg Oncol. 1990;16:1121–1126
  143. Harrison PV. Good results after shave excision of benign moles. J Dermatol Surg Oncol. 1985;11:668–686
  144. Gambichler T, Senger E, Rapp S, Alamouti D, Altmeyer P, Hoffmann K. Deep shave excision of macular melanocytic nevi with the razor blade biopsy technique. Dermatol Surg. 2000;26:662–666
  145. Bong JL, Perkins W. Shave excision of benign facial melanocytic naevi: a patient's satisfaction survey. Dermatol Surg. 2003;29:227–229
  146. Zanardini Pereira CA, de Oliveira de Avelar Alchorne A. Tangential excision of nevocellular nevus on the face. Int J Dermatol. 2004;43:533–537
  147. Ferrandiz L, Moreno-Ramirez D, Camacho FM. Shave excision of common acquired melanocytic nevi: cosmetic outcome, recurrences, and complications. Dermatol Surg. 2005;31:1112–1115
  148. Schoenfeld RJ, Pinkus H. The recurrence of nevi after incomplete removal. AMA Arch Derm. 1958;78:30–35
  149. Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol. 1975;111:1588–1590
  150. Cohen LM, Hodge SJ, Owen LG, Callen JP. Atypical melanocytic nevi. Clinical and histopathologic predictors of residual tumor at reexcision. J Am Acad Dermatol. 1992;27:701–706
  151. Barnhill RL, Hurwitz S, Duray PH, Arons MS. The dysplastic nevus: recognition and management. Plast Reconstr Surg. 1988;81:280–289
  152. Hamilton S, Gault D. Combined shave-excision in removal of benign naevi. J Plast Reconstr Aesthet Surg. 2006;59:110–111
  153. Lo SJ, Khoo C. Improving the cosmetic acceptability of punch biopsies: a simple method to reduce dog-ear formation. Plast Reconstr Surg. 2006;118:295–296
  154. Tursen U, Kaya TI, Ikizoglu G. Surgical approach to benign small papular and dome-shaped melanocytic naevi on the face. J Cosmet Dermatol. 2003;2:175–179
  155. Lum D, Lum RS. Razor blade surgery: use of the Castroviejo blade breaker and holder. Dermatol Surg. 1999;25:143–144
  156. Marghoob AA, Swindle LD, Moricz CZ, Sanchez Negron FA, Slue B, Halpern AC, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol. 2003;49:777–797quiz 798-9
  157. Wachsman W, Zapala M, Udall D, Paik A, Hata T, Walls L, et al. Differentiation of melanoma from dysplastic nevi in suspicious pigmented lesions by non-invasive tape-stripping. Los Angeles: Society of Investigative Dermatology Conference; 2007;
  158. Morhenn VB, Chang EY, Rheins LA. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol. 1999;41:687–692
  159. Wong R, Tran V, Morhenn V, Hung SP, Andersen B, Ito E, et al. Use of RT-PCR and DNA microarrays to characterize RNA recovered by non-invasive tape harvesting of normal and inflamed skin. J Invest Dermatol. 2004;123:159–167
  160. Wong R, Tran V, Talwalker S, Benson NR. Analysis of RNA recovery and gene expression in the epidermis using non-invasive tape stripping. J Dermatol Sci. 2006;44:81–92
  161. Benson NR, Papenfuss J, Wong R, Motaal A, Tran V, Panko J, et al. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting. J Invest Dermatol. 2006;126:2234–2241
  162. Hoek KS. DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res. 2007;20:466–484
  163. Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, Hill J, et al. Molecular diagnostics in melanoma. J Am Acad Dermatol. 2005;52:743–775quiz 775-8
  164. Carr KM, Bittner M, Trent JM. Gene-expression profiling in human cutaneous melanoma. Oncogene. 2003;22:3076–3080
  165. Schindewolf T, Schiffner R, Stolz W, Albert R, Abmayr W, Harms H. Evaluation of different image acquisition techniques for a computer vision system in the diagnosis of malignant melanoma. J Am Acad Dermatol. 1994;31:33–41
  166. Andreassi L, Perotti R, Rubegni P, Burroni M, Cevenini G, Biagioli M, et al. Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma: a new quantitative semiology. Arch Dermatol. 1999;135:1459–1465
  167. Wollina U, Burroni M, Torricelli R, Gilardi S, Dell'Eva G, Helm C, et al. Digital dermoscopy in clinical practise: a three-centre analysis. Skin Res Technol. 2007;13:133–142
  168. Seidenari S, Pellacani G, Giannetti A. Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Res. 1999;9:163–171
  169. Menzies SW. Automated epiluminescence microscopy: human vs machine in the diagnosis of melanoma. Arch Dermatol. 1999;135:1538–1540
  170. Menzies SW, Bischof L, Talbot H, Gutenev A, Avramidis M, Wong L, et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Arch Dermatol. 2005;1411388–1411396
  171. Rosado B, Menzies S, Harbauer A, Pehamberger H, Wolff K, Binder M, et al. Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis. Arch Dermatol. 2003;139:361–367discussion 366
  172. Perrinaud A, Gaide O, French LE, Saurat JH, Marghoob AA, Braun RP. Can automated dermoscopy image analysis instruments provide added benefit for the dermatologist? A study comparing the results of three systems. Br J Dermatol. 2007;157:926–933
  173. Boldrick JC, Layton CJ, Nguyen J, Swetter SM. Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. J Am Acad Dermatol. 2007;56:417–421
  174. Menzies SW. Cutaneous melanoma: making a clinical diagnosis, present and future. Dermatol Ther. 2006;19:32–39

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)00657-9

doi: 10.1016/j.jaad.2008.05.027

Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 852-871 , November 2008

Article Tools

* Image Usage & Resolution